Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus

Sung Hwan Yun1, Georgi Gamkrelidze, W Blaine Stine

  • 1Department of Pediatrics and Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60614, USA.

Neuroscience Letters
|June 13, 2006
PubMed

Insights

Oligomeric amyloid-beta (Abeta) decreases neuronal excitability in the hippocampus, potentially explaining Alzheimer's disease-related memory loss. This finding links Abeta's impact on neuroplasticity to cognitive decline in Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Amyloid-beta (Abeta) is a key factor in Alzheimer's disease (AD) pathogenesis.
  • Neuroplasticity failure is a proposed mechanism for early AD.
  • Oligomeric Abeta(1-42) has been shown to inhibit long-term potentiation (LTP) in rat hippocampal slices.

Purpose of the Study:

  • To investigate the effect of oligomeric Abeta(1-42) on neuronal excitability in hippocampal granule cells.
  • To determine if reduced neuronal excitability underlies Abeta-mediated neuroplasticity impairment in Alzheimer's disease.

Main Methods:

  • Whole-cell recordings were performed in hippocampal granule cells of rat slices.
  • Oligomeric Abeta(1-42) was applied to the slices.
  • Neuronal excitability was assessed by measuring action potential firing in response to current injection and the amplitude of the afterhyperpolarization.

Main Results:

  • Oligomeric Abeta(1-42) significantly decreased neuronal excitability.
  • A reduction in the number of action potentials fired upon current injection was observed.
  • An increase in the amplitude of the afterhyperpolarization was measured after Abeta(1-42) application.

Conclusions:

  • Oligomeric Abeta(1-42) reduces neuronal excitability in hippocampal granule cells.
  • This reduced excitability may be a critical mechanism for Abeta-induced neuroplasticity deficits.
  • The findings suggest a link between Abeta, impaired neuroplasticity, and memory loss in Alzheimer's disease.

Related Concept Videos